DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Inoue A, Kobayashi K, Usui K. et al
North East Japan Gefitinib Study Group. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
J Clin Oncol 2009;
27 (09) 1394-1400
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.